ctrl K

Watchlist Price Alert

Revelation Biosciences In... (REVB)

NASDAQ: REVB · Real-Time Price · USD

0.79

-0.03 (-3.66%)

At close: Jun 26, 2025, 3:59 PM

Revelation Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	6.5M	11.99M	5.25M	1.27M	4.49M	n/a
Short-Term Investments	n/a	n/a	n/a	n/a	525.29K	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	73.51M	n/a
Other Long-Term Assets	n/a	n/a	n/a	0.00	n/a	22.67K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	49.5K	100.61K	160.3K	148.73K	n/a	n/a
Total Current Assets	6.57M	12.15M	5.41M	1.91M	4.62M	n/a
Property-Plant & Equipment	56.33K	65.08K	90.13K	130.14K	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	56.33K	65.08K	90.13K	130.14K	73.51M	22.67K
Total Assets	6.62M	12.21M	5.5M	2.04M	4.62M	22.67K
Account Payables	783.62K	1.36M	554.21K	596.26K	865.9K	n/a
Deferred Revenue	n/a	n/a	2.91M	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	294.32K	3.44M	3.28M	771.94K	n/a	26.31K
Total Current Liabilities	1.91M	5.56M	4.45M	2.14M	1.21M	26.31K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	554.21K	2.91M	2.91M	n/a
Total Liabilities	1.91M	5.56M	4.45M	2.14M	1.21M	26.31K
Total Debt	n/a	n/a	n/a	16.75K	n/a	n/a
Common Stock	522.00	265.00	683.00	2.31K	2.29K	n/a
Retained Earnings	-40.51B	-25.47M	-25.35M	-14.52M	-2.53M	-3.64K
Comprehensive Income	n/a	-0.00	n/a	-0.00	n/a	n/a
Shareholders Equity	4.71B	6.65M	1.05M	-99.47K	3.41M	-3.64K
Total Investments	6.49B	n/a	n/a	n/a	525.29K	n/a